Announcements Trials

Browse Landscape

Phase

Phase NA 5 Phase 2 2 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Cancer, Papillary 1 Lymphatic Metastasis 1

Interventions

Cyclophosphamide 415 Radiotherapy 274 fludarabine 237 Gemcitabine 210 Cisplatin 202 Nivolumab 184 pembrolizumab 181 Paclitaxel 176 Carboplatin 167 Magnetic Resonance Spectroscopy 163 fludarabine phosphate 156 Irinotecan 134 Bevacizumab 133 Cytarabine 128 Capecitabine 124 Temozolomide 123 Specimen Handling 122 Radiosurgery 117 Docetaxel 116 Biopsy 115 Ipilimumab 114 Dexamethasone 113 Radiation 109 Oxaliplatin 109 Fluorouracil 109 Etoposide 108 Rituximab 107 Filgrastim 99 Lenalidomide 98 Everolimus 96

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × OTHER × Spectrum Analysis × Clear all

NCT03470259 2024-04-16

TARGET

University Medical Center Groningen

Phase 1 Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡